DeepMed Research

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma

Not Applicable

Recruiting

Conditions: Glioblastoma
Glioblastoma Multiforme

Interventions: Device: Sonobiopsy
Procedure: Research blood
Genetic: Cancer Personalized Profiling
Device: Definity®

First Posted Date: 2022-03-16

Last Posted Date: 2024-10-29

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT05281731

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Development and Translation of Generator-Produced PET Tracer for Myocardial Perfusion Imaging-Dosimetry Group

Early Phase 1

Completed

Conditions: Coronary Artery Disease

Interventions: Drug: Ga-68 Galmydar

First Posted Date: 2022-03-15

Last Posted Date: 2023-09-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 8

Registration Number: NCT05280782

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)

Recruiting

Conditions: Type 2 Diabetes Mellitus in Obese
Cognitive Decline
Brain Structure
Diabetes in Adolescence
Inflammation
Overweight, Childhood
Type2 Diabetes
Dysglycemia
Obesity, Childhood
Insulin Resistance

Interventions: Other: Observational

First Posted Date: 2022-03-14

Last Posted Date: 2024-04-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 117

Registration Number: NCT05277558

Locations: 🇺🇸
UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Utilizing Social Contacts to Facilitate Mammogram Screening Among African American Women

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Social Contact Reminder

First Posted Date: 2022-03-11

Last Posted Date: 2022-07-07

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 156

Registration Number: NCT05275361

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)

Phase 2

Active, not recruiting

Conditions: Alzheimers Disease
Dementia
Alzheimers Disease, Familial

Interventions: Drug: E2814
Drug: Matching Placebo (E2814)
Drug: Lecanemab

First Posted Date: 2022-03-08

Last Posted Date: 2025-04-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 197

Registration Number: NCT05269394

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
USC Keck School of Medicine, Los Angeles, California, United States
🇨🇴
Grupo de Neurociencias Sede de la Universidad de Antioquia, Medellín, Colombia

and more 35 locations

A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer Survivors

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Other: Low AGE diet
Procedure: Research blood draw

First Posted Date: 2022-03-03

Last Posted Date: 2025-01-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 14

Registration Number: NCT05265715

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid

Phase 2

Terminated

Conditions: Mucous Membrane Pemphigoid
Cicatrizing Conjunctivitis

Interventions: Drug: Methotrexate
Drug: Baricitinib 2 MG [Olumiant]
Drug: Azathioprine
Drug: Mycophenolate

First Posted Date: 2022-03-02

Last Posted Date: 2023-11-07

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 2

Registration Number: NCT05263505

Locations: 🇺🇸
Barnes Jewish Hospital / Washington University in St. Louis, Saint Louis, Missouri, United States

Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)

Phase 2

Withdrawn

Conditions: Brain Metastases
Triple Negative Breast Cancer

Interventions: Drug: Pembrolizumab
Drug: Liposomal Irinotecan

First Posted Date: 2022-02-24

Last Posted Date: 2023-07-11

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT05255666

Samaki Salama: Small-scale Fisheries for Healthy Nutrition and Ecosystems

Not Applicable

Conditions: Malnutrition, Child
Growth; Stunting, Nutritional

Interventions: Behavioral: Social marketing
Behavioral: social marketing + gear modification

First Posted Date: 2022-02-24

Last Posted Date: 2022-02-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1200

Registration Number: NCT05254444

Locations: 🇰🇪
Pwani University, Kilifi, Kenya

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

Phase 2

Terminated

Conditions: Ampullary Cancer
Pancreas Neuroendocrine Tumor
Pancreatitis
Pancreatic Cancer
Distal Extrahepatic Cholangiocarcinoma
Pancreas Cancer
Duodenal Cancer

Interventions: Drug: Placebo
Drug: Pantoprazole

First Posted Date: 2022-02-22

Last Posted Date: 2025-05-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 56

Registration Number: NCT05251233

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy